an inquiry into fto and bisantrene: race oncology (asx:rac)
Published 3 years ago • 2.4K plays • Length 40:10Download video MP4
Download video MP3
Similar videos
-
33:41
a speculative peer m&a comparison for value: race oncology (asx: rac)
-
19:11
sharecafe 'hidden gems' webinar - race oncology asx:rac
-
4:59
race oncology (asx:rac) lists on asx
-
6:42
race oncology looks to accelerate clinical development of bisantrene
-
4:36
race oncology partners with george clinical for rc220 bisantrene trials
-
24:17
andexanet for factor xa inhibitor-associated acute intracerebral hemorrhage: the annexa-i trial
-
8:26
pembahasan intan pariwara biologi kelas 10 asesmen 2
-
17:40
race leadership team strengthened
-
11:26
race oncology's daniel tillett details positive preclinical results for bisantrene in breast cancer
-
6:49
race oncology receives positive results from aml trial of bisantrene
-
0:52
asx market open video 11th june 🚀
-
27:43
race presents at ird invest
-
2:17
what are the near term value drivers for race oncology
-
2:45
race oncology welcomes positive pre-ind meeting for zantrene
-
0:47
race oncology bisantrene production
-
8:05
race oncology receives us fda rare paediatric disease designation for aml treatment
-
1:01
asx market open video 11th june
-
1:44
what is race oncology?
-
0:39
are afib related strokes more disabling than others?